Full-Time

Quality Analyst

Posted on 4/15/2025

Axogen

Axogen

201-500 employees

Develops technologies for peripheral nerve repair

Compensation Overview

$55.1k - $68.8k/yr

+ Bonus

Entry, Junior

Mansfield, TX, USA

Category
Diagnostics & Laboratory Professionals
Medical, Clinical & Veterinary
Required Skills
Excel/Numbers/Sheets
Requirements
  • Bachelor’s Degree in a Life Science discipline, engineering, or in a related field preferred.
  • High School Diploma and minimum of 0-2 years of relevant industry experience within a Medical Device, Pharmaceutical, or Tissue commercial organization.
  • Familiarity with ANSI/ASQ Z1.4-2003, c=0 and AQL methodologies preferred
  • Experience in an FDA-regulated environment, particularly medical device, human tissue or pharmaceutical manufacturing preferred.
  • Experience with Microsoft Excel
  • Experience writing Standard Operating Procedures and Work Instructions
  • Experience with Quality System elements for CAPA, Non-Conforming Reports (NCRs) and Deviations
Responsibilities
  • Performs reviews of batch production records and manufacturing records as part of lot release activities.
  • Coordinates and tracks CAPA, NCR, and Deviation records, ensuring tasks are completed on time.
  • Coordinates and tracks the site environmental monitoring (EM) testing program.
  • Assists teams in coordination of problem solving and root cause analysis for associated quality events.
  • Ensures the development, review, and release of quarterly EM trending reports; ensures significant trends are immediately brought to management attention.
  • Provides input based on knowledge and experience with batch release requirements.
  • Provides QMS Operations related support to all CGMP departments.
  • Performs Quality Control activities at AxoGen’s processing or distribution sites. The Quality Analyst will be responsible for incoming material inspections, in-process inspections, and finished product inspections.
  • Products include Medical Devices, sterile processed Human Tissue-Based Products, unprocessed human tissue, component supplies, and labeling materials.
  • The Quality Analyst will maintain accurate and complete records of Quality Control activities, following Good Documentation Practices.
  • Provides support related to gowning qualification and training.
  • Ensures timely issuance, review, and approval of Microbiology and EM testing results.
  • Interfaces with colleagues to ensure effective corrective and preventive actions are implemented for any recurring product/process discrepancies.
  • Assists in the review and approval of equipment qualifications.
  • Assists in the review of Calibration and Preventative Maintenance reviews.
  • Assists in hosting of onsite regulatory audits and inspections.
Desired Qualifications
  • Bachelor’s Degree in a Life Science discipline, engineering, or in a related field preferred.
  • Familiarity with ANSI/ASQ Z1.4-2003, c=0 and AQL methodologies preferred
  • Experience in an FDA-regulated environment, particularly medical device, human tissue or pharmaceutical manufacturing preferred.

Axogen specializes in developing and commercializing technologies aimed at repairing and regenerating peripheral nerves. Their products are designed to assist surgeons and healthcare providers in restoring nerve function for patients who have experienced physical damage or discontinuity in their peripheral nerves due to traumatic injuries or surgical procedures. Axogen's solutions help address issues such as loss of muscle function, sensory feeling, and pain caused by nerve damage. What sets Axogen apart from its competitors is its dedicated focus on peripheral nerve repair, offering a comprehensive range of clinically proven and cost-effective products. The company's goal is to improve the quality of life for patients by enabling them to regain essential functions like touch, movement, and sensation.

Company Size

201-500

Company Stage

IPO

Headquarters

Alachua, Florida

Founded

2002

Simplify Jobs

Simplify's Take

What believers are saying

  • Axogen's new CFO, Lindsey Hartley, brings fresh financial leadership from May 2025.
  • The launch of Avive+ Soft Tissue Matrix enhances Axogen's product portfolio.
  • Rolling submission of Avance Nerve Graft BLA marks regulatory progress.

What critics are saying

  • Increased competition from emerging biotech companies threatens Axogen's market share.
  • Potential FDA approval delays for Avance Nerve Graft could impact timelines.
  • Recent public stock offering may lead to stock dilution and affect investor confidence.

What makes Axogen unique

  • Axogen specializes in surgical solutions for peripheral nerve injuries.
  • Avive+ Soft Tissue Matrix offers temporary protection during nerve healing.
  • Axogen initiated a Biologics License Application for Avance Nerve Graft in May 2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Holidays

Employee Stock Purchase Plan

Tuition Reimbursement

Paid Parental Leave

Paid Caregiver Leave

Basic Life Insurance

Supplemental Life Insurance

Disability Insurance

Company News

RTTNews
May 8th, 2025
Axogen Promotes Lindsey Hartley To Succeed Nir Naor As CFO

Axogen, Inc. (AXGN), a developer of innovative surgical solutions for peripheral nerve injuries, announced the appointment of Lindsey Hartley as Chief Financial Officer, effective May 12, 2025.

Health Promo
Mar 26th, 2025
Axogen Announces Appointment of Rick Ditto as Vice

ALACHUA, Fla. and TAMPA, Fla., March 24, 2025 (GLOBE NEWSWIRE) - Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy.

Market Wire News
Jan 10th, 2025
AXGN - Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) - Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Craig Swandal as Vice President of Operations.

Investor Brand Network
Nov 7th, 2024
BioMedNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Strengthens Clinical Research Team with Appointment of Senior Clinical Scientist

Dr. Peterson, an experienced clinical researcher with a background in both academic and industry roles, joins from Axogen, where he specialized in therapies for peripheral nerve repair.

MedTech Dive
Aug 9th, 2024
Axogen names ex-Abbott exec Michael Dale as CEO

Axogen names ex-abbott exec Michael Dale as CEO.

INACTIVE